Chinese English Japanese Korean

LangFangshi Hengfuyuan Pharma Tech CO.,Itd.

Firmenname:LangFangshi Hengfuyuan Pharma Tech CO.,Itd.
Telefon:0316-2883536
E-Mail:1877241811@qq.com
Nationalität:China
URL: www.zkhfychem.com/
Produkte insgesamt:2043
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Produktkatalog

2'-(1H-Tetrazol-5-yl)-1,1'-biphenyl-4-carboxaldehyde (Losartan IMpurity)151052-40-3C14H10N4O
2'-(Triphenylmethyltetrazol-5-yl)biphenyl-4-yl]carboxaldehyde;Olmesartan Impurity 81155983-56-5C33H24N4O
diethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate144690-53-9C45H42N6O4
Irbesartan Impurity 14133690-91-2C25H28N6O
Irbesartan Impurity 3152708-24-2C14H11N7
Olmesartan Medoxomil Impurity E144689-23-6C26H30N6O3
Losartan EP Impurity B160514-13-6C14H12N4O
Olmesartan Medoxomil Impurity 25;2-propyl-1H-imidazole-4,5-dicarboxylic acid144690-04-0C10H16N2O3
Olmesartan144689-24-7C24H26N6O3
1H-Imidazole-4-carboxylic acid, 5-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester1048948-20-4C29H30N6O6
(4-ETHOXY-2-OXO-2,5-DIHYDRO-PYRROL-1-YL)-ACETIC ACID142274-08-6C8H11NO4
4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid2758005-15-9C14H11N3O2
Irbesartan Impurity 242763750-28-1C14H12N4O
2(e),4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetraazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester1203671-69-5C48H44N6O6
Telmisartan Impurity 10136304-93-3C14H10ClN
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1820891-36-8C22H22N6O3
diethyl 2-propylimidazoledicarbonate144689-94-1C12H18N2O4
DMDO37830-90-3C5H6O3
PiracetamPiracetam7491-74-9C6H10N2O2
Olmesartan Impurity 5258954-23-7C8H10N2O4
GLYCINE ANHYDRIDEPiperazin-2,5-dion106-57-0C4H6N2O2
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole124750-53-4C33H26N4
Irbesartan Impurity 15154709-19-0C14H11NO
1,3-Benzenediamine, 4,6-dimethoxy-N1-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1942853-79-3C21H21N5O2
oxiracetam impurity III62833-66-3C6H8N2O2
oxiracetam impurity VI85614-52-4C7H11NO4
4-hydroxypyrrolidin-2-one25747-41-5C4H7NO2
oxiracetam impurity IV77191-37-8C6H9NO4
oxiracetaM related substance ISF3886120428-80-0C8H13N3O4
oxiracetam impurity VIIEthyl-4-hydroxy-2-oxopyrrolidin-1-acetat62613-81-4C8H13NO4
Osimertinib Impurity 212213409-62-0C23H20FN5O2
Osimertinib Impurity 191421373-33-2C32H39N7O4
Osimertinib Impurity 151421373-34-3C29H37N7O3
Osimertinib Impurity 161421373-31-0C24H29N7O
2-Pyrimidinamine, N-(2,4-dimethoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)-1942853-78-2C21H19N5O4
1-Piperazinecarboxylic acid, 4-[3-methoxy-4-[[2-[[3-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-, 1,1-dimethylethyl ester2120319-14-2C30H34F3N7O4
Vonoprazan Impurity 141807642-39-2C16H10FN3O2S
Osimertinib Impurity 221421372-34-0C19H14FN5O3
Vonoprazan Impurity1885094-63-2C21H20FN3O6S
Vonoprazan Impurity312307-69-0C11H7FN2O
2-Propenamide, N-[3-[[4-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]phenyl]-1888303-01-2C27H28F3N7O3
TAK438 Impurity 1122932441-73-9
Osimertinib Impurity 231421373-99-0C27H31N7O2
Vonoprazan Impurity X Fumaric acid928325-82-0C21H21N3O6S
Osimertinib Impurity 292408329-87-1C24H27N7O3
1548527-26-9C31H37F3N8O4
Osimertinib Impurity 141421373-32-1C24H27N7O3
N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide2044702-39-6C25H26N6O2
Osimertinib Impurity 111975982-94-5C28H33N7O3
(2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol154709-18-9C33H26N4O
Vonoprazan Impurity D881674-58-4C11H10FNO
Osimertinib Impurity 301421373-36-5C28H34ClN7O2
2-Propenamide, N-[2,4-dimethoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-1942853-18-0C24H23N5O3
Osimertinib Impurity 172227103-37-7C27H33N7O2
Osimertinib Impurity 181801616-92-1C22H24N6O
Olmesartan Medoxomil Impurity 321040405-56-8C49H46N6O6
Osimertinib Impurity 201801616-73-8C20H18FN5O
Osimertinib Impurity 131421373-35-4C29H35N7O5
Osimertinib Impurity 121932710-29-6C31H35N7O3
2-Propenamide, N-[3-[[2-[[2-methoxy-4-(1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2763827-03-6C25H26F3N7O2
Osimertinib Impurity I2044702-55-6C22H25ClN6O
Ethanone, 1-[4-[4-[[2-[(3-aminophenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]-3-methoxyphenyl]-1-piperazinyl]-2044703-15-1C24H26F3N7O2
Benzofuran-6-carboxylicacid(LifitegrastImpurity)77095-51-3C9H6O3
Celecoxib Carboxylic Acid170571-01-4C17H12F3N3O4S
Vonoprazan Impurity 102169271-28-5C16H13FN2O3S
Lifitegrast Impurity 82271299-08-0C29H24Cl2N2O7S
Lifitegrast Impurity 72129597-34-6C19H13Cl2NO4
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate1194550-67-8C36H30Cl2N2O7S
methyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl) propanoate hydrochloride2758051-12-4C21H23Cl3N2O5S
2982988-09-8C19H17NO6S
Celecoxib Impurity 3053764-99-1C11H9F3O2
Gluconic acidD-Gluconsure526-95-4C6H12O7
Celecoxib Impurity A170570-01-1C17H14F3N3O2S
Celecoxib Impurity F170569-99-0C17H14F3N3O2S
(R)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoic acid1270132-45-0C10H13NO4S
5,7-dichloro-1,2,3,4-tetrahydroisoquinoline89315-56-0C9H9Cl2N
Isoquinoline, 5,7-dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)-1289646-72-5C28H23Cl2N
Boc-3-(Methylsulfonyl)-L-Phenylalanine1289646-76-9C15H21NO6S
Vonoprazan Impurity1883595-37-6C16H11FN2O4S
Lifitegrast Impurity 262295862-29-0C30H26Cl2N2O7S
Lifitegrast Impurity 282982988-08-7C26H23NO6S
4,4,4-Trifluoro-1-(p-tolyl)-1,3-butanedione720-94-5C11H9F3O2
Celecoxib iMpurity-G1061214-06-9C15H17N3O2S
2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid851784-82-2C15H17Cl2NO4
ifitegrast impurity C851785-70-1C20H20Cl2N2O5S
Celebrex P921617-76-7C17H13F3N2O3S
Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]-1135952-91-8C14H15N3O2S
benzyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate1194550-59-8C17H20ClNO4S
2(1H)-Isoquinolinecarboxylic acid, 5,7-dichloro-3,4-dihydro-6-[[[(1S)-1-[[3-(methylsulfonyl)phenyl]methyl]-2-oxo-2-(phenylmethoxy)ethyl]amino]carbonyl]-, 1,1-dimethylethyl ester1194550-61-2C32H34Cl2N2O7S
4,4,4-Trifluoro-1-phenyl-1,3-butanedione4,4,4-Trifluor-1-phenylbutan-1,3-dion326-06-7C10H7F3O2
Lifitegrast Impurity 512177264-60-5C10H14ClNO4S
Vonoprazan Impurity U91885094-62-1C18H18FN3O2S
2(1H)-Isoquinolinecarboxylic acid, 5,7-dichloro-3,4-dihydro-, 1,1-dimethylethyl ester2215846-47-0C14H17Cl2NO2
Lifitegrast Impurity 31194550-65-6C27H27Cl3N2O5S
6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride1289646-93-0C10H10Cl3NO2
ethyl benzofuran-6-carboxylate；Lifitegrast Impurity 321289646-90-7C11H10O3
Vonoprazan Impurity1831110-76-9C22H24FN3O4S
Celecoxib Impurity 3170569-87-6C16H12F3N3O2S
Lifitegrast Impurity 152049127-88-8C17H20ClNO4S
Celecoxib Impurity 172247197-65-3C17H14F3N3O4S
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Copyright 2019 © ChemicalBook. All rights reserved